Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 May 21 EFFECT Notice of effectiveness
- 21 May 21 424B3 Prospectus supplement
- 21 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
19 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 16 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Jan 21 S-4 Registration of securities issued in business combination transactions
NRXP similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
NeuroRx, Inc.:
We consent to the use of our report dated May 11, 2021, with respect to the consolidated financial statements of NeuroRx, Inc., included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP |
Short Hills, New Jersey
May 18, 2021